Tigecycline 50 Mg Pfizer 50 mg Sterile Powder for Intravenous Infusion
PDF Leaflet Revision Date: 21 February 2023
Clinical Summary
Quick overview from the medicine insert
Indication
Severe life-threatening infections in adults.
Dosage (summary)
Initial 100 mg IV, then 50 mg every 12 hours.
Onset of Action / Duration
Onset: Not specified, Duration: 5-14 days.
Special Populations
- Renal impairment
- Hepatic impairment
- Elderly
Pregnancy & Breastfeeding
Contraindicated in pregnancy and breastfeeding.
Key Drug Interactions
- Warfarin
- Digoxin
- Calcineurin inhibitors
Contraindications
- Hypersensitivity to tigecycline or excipients
- Pregnancy
- Lactation
Common side effects
- Nausea
- Vomiting
- Diarrhoea
- Dizziness
- Rash
Counselling Points
- Monitor for allergic reactions
- Avoid in pregnancy
- Report severe gastrointestinal symptoms
Serious warnings
- Increased all-cause mortality
- Not for HAP or VAP
- Risk of pancreatitis
Important Disclaimer
The Tigecycline 50 Mg Pfizer 50 mg Sterile Powder for Intravenous Infusion professional information leaflet below is the property of Pfizer Laboratories and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
